This review summarizes recent advances in the understanding of causes, pathogenesis, natural history, diagnosis, and treatment of acute myocarditis.
Answers are grounded in this paper and cite their sources.
Advances in acute myocarditis understanding warrant cautious clinical application; leaves open need for prospective trials to guide practice.
Myocarditis is defined as inflammation of the myocardium accompanied by myocellular necrosis. Acute myocarditis must be considered in patients who present with recent onset of cardiac failure or arrhythmia. Often there is a history of an antecedent flu-like illness. Fulminant myocarditis is a distinct entity characterized by sudden onset of severe congestive heart failure or cardiogenic shock, usually following a flu-like illness. Giant cell myocarditis is a rare, frequently fatal disorder of unknown origin characterized by presence of giant cell inflammatory infiltrate in the myocardium. In recent years we have made good progress in understanding the causes, pathogenesis, natural history, diagnosis, and treatment of myocarditis. However, our knowledge is still far from complete. New information that extends our understanding of myocarditis is being reported constantly. This review summarizes recent advances in myocarditis, with an emphasis on the literature during the last year.
No takes yet. Share an insight, caveat, or question.
Batra et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: